Brentuximab vedotin as a salvage treatment for relapsed and refractory Hodgkin lymphoma patients in Taiwan
Author:
Publisher
Elsevier BV
Subject
General Medicine
Reference13 articles.
1. Long-term survival after treatment for Hodgkin's disease (1973–2002): improved survival with successive 10-year cohorts;Bessell;Br J Cancer,2012
2. Brentuximab vedotin: a CD30-directed antibody-cytotoxic drug conjugate;Newland;Pharmacotherapy,2013
3. Results of a pivotal phase II study of brentuximab vedotin for patients with relapsed or refractory Hodgkin's lymphoma;Younes;J Clin Oncol – Offic J Am Soc Clin Oncol,2012
4. Clinicopathological features of malignant lymphoma in Japan: the Miyagi study;Miura;Tohoku J Exp Med,2011
5. Lymphoma in Taiwan: Review of 1347 neoplasms from a single institution according to the 2016 revision of the world health organization classification;Chuang;J Formosan Med Assoc Taiwan yi zhi,2017
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Investigating early progression of Hodgkin lymphoma in a two-center analysis;Journal of the Formosan Medical Association;2022-07
2. The Role of Brentuximab Vedotin (BV) as Second-Line Treatment of Refractory Classical Hodgkin Lymphoma (cHL) in the Era of Pandemic COVID-19;International Medical Case Reports Journal;2022-06
3. Brentuximab-Induced Peripheral Neurotoxicity: A Multidisciplinary Approach to Manage an Emerging Challenge in Hodgkin Lymphoma Therapy;Cancers;2021-12-05
4. Effectiveness of brentuximab vedotin monotherapy in relapsed or refractory Hodgkin lymphoma: a systematic review and meta-analysis;Leukemia & Lymphoma;2021-07-29
5. Brentuximab vedotin;Reactions Weekly;2019-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3